Ilyas S - Search Results

1

Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma.

Loeuillard E, Yang J, Buckarma E, Wang J, Liu Y, Conboy C, Pavelko KD, Li Y, O'Brien D, Wang C, Graham RP, Smoot RL, Dong H, Ilyas S. Loeuillard E, et al. Among authors: ilyas s. J Clin Invest. 2020 Oct 1;130(10):5380-5396. doi: 10.1172/JCI137110. J Clin Invest. 2020. PMID: 32663198 Free PMC article.

2

Targeting the tumor microenvironment in cholangiocarcinoma: implications for therapy.

Wang J, Ilyas S. Wang J, et al. Among authors: ilyas s. Expert Opin Investig Drugs. 2021 Apr;30(4):429-438. doi: 10.1080/13543784.2021.1865308. Epub 2020 Dec 28. Expert Opin Investig Drugs. 2021. PMID: 33322977 Free PMC article. Review.

3

MEK Inhibition: A New Ally in Immunotherapy for Intrahepatic Cholangiocarcinoma.

Loeuillard E, Gores GJ, Ilyas SI. Loeuillard E, et al. Cell Mol Gastroenterol Hepatol. 2021;12(3):1153-1154. doi: 10.1016/j.jcmgh.2021.06.019. Epub 2021 Jul 6. Cell Mol Gastroenterol Hepatol. 2021. PMID: 34242622 Free PMC article. No abstract available.

4

Cholangiocarcinoma.

Brindley PJ, Bachini M, Ilyas SI, Khan SA, Loukas A, Sirica AE, Teh BT, Wongkham S, Gores GJ. Brindley PJ, et al. Among authors: ilyas si. Nat Rev Dis Primers. 2021 Sep 9;7(1):65. doi: 10.1038/s41572-021-00300-2. Nat Rev Dis Primers. 2021. PMID: 34504109 Free PMC article. Review.

5

FGFR Inhibitor Toxicity and Efficacy in Cholangiocarcinoma: Multicenter Single-Institution Cohort Experience.

Gile JJ, Ou FS, Mahipal A, Larson JJ, Mody K, Jin Z, Hubbard J, Halfdanarson T, Alberts SR, Jatoi A, McWilliams RR, Ma WW, Ilyas S, Smoot R, Roberts L, Gores G, Borad M, Bekaii-Saab TS, Tran NH. Gile JJ, et al. Among authors: ilyas s. JCO Precis Oncol. 2021 Jul 28;5:PO.21.00064. doi: 10.1200/PO.21.00064. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34778691 Free PMC article.

6

Cholangiocarcinoma: what are the most valuable therapeutic targets - cancer-associated fibroblasts, immune cells, or beyond T cells?

Wang J, Loeuillard E, Gores GJ, Ilyas SI. Wang J, et al. Expert Opin Ther Targets. 2021 Oct;25(10):835-845. doi: 10.1080/14728222.2021.2010046. Epub 2021 Dec 3. Expert Opin Ther Targets. 2021. PMID: 34806500 Free PMC article.

7

Hepatology Highlights.

Watkins R, Ilyas SI, Penrice DD, Conboy CB, Ayares G, Arab JP. Watkins R, et al. Hepatology. 2022 Feb;75(2):241-242. doi: 10.1002/hep.32295. Hepatology. 2022. PMID: 35040177 No abstract available.

8

PD-L1 promotes myofibroblastic activation of hepatic stellate cells by distinct mechanisms selective for TGF-β receptor I versus II.

Sun L, Wang Y, Wang X, Navarro-Corcuera A, Ilyas S, Jalan-Sakrikar N, Gan C, Tu X, Shi Y, Tu K, Liu Q, Lou Z, Dong H, Sharpe AH, Shah VH, Kang N. Sun L, et al. Among authors: ilyas s. Cell Rep. 2022 Feb 8;38(6):110349. doi: 10.1016/j.celrep.2022.110349. Cell Rep. 2022. PMID: 35139382 Free PMC article.

9

Emerging immunotherapy for HCC: A guide for hepatologists.

Foerster F, Gairing SJ, Ilyas SI, Galle PR. Foerster F, et al. Hepatology. 2022 Jun;75(6):1604-1626. doi: 10.1002/hep.32447. Epub 2022 Apr 7. Hepatology. 2022. PMID: 35253934 Free PMC article. Review.

10

Hepatology highlights.

Conboy CB, Penrice DD, Watkins R, Díaz LA, Arab JP, Ilyas SI. Conboy CB, et al. Hepatology. 2022 May;75(5):1071-1072. doi: 10.1002/hep.32488. Hepatology. 2022. PMID: 35460099 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

290 results

Search Page